Paid Clinical Trials Cincinnati

Discover 720 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 720

LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Recruiting

PHASE3

Sponsor:

Intra-Cellular Therapies, Inc.

Location:

Cincinnati OH, Indianapolis IN, Avon Lake OH, Westlake OHshow 38 more

Code:

NCT06372964

Conditions

Bipolar Depression

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

Lumateperone

Placebo

TirzepatideA Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Covington KY, Indianapolis IN, Lima OH, Springfield ILshow 27 more

Code:

NCT06914895

Conditions

Type 1 Diabetes

Obesity

Overweight

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tirzepatide

Placebo

FT825/ONO-8250 & Monoclonal AntibodiesFT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, with or Without Monoclonal Antibodies in Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

Fate Therapeutics

Location:

Cincinnati OH, Columbus OH, Detroit MI, Nashville TNshow 10 more

Code:

NCT06241456

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FT825

Fludarabine

Cyclophosphamide

Bendamustine

Docetaxel

Observational StudySimplified Ultrasound Feedback for Speech Remediation

Recruiting

Sponsor:

University of Cincinnati

Location:

Cincinnati OH

Code:

NCT06366256

Conditions

Speech Sound Disorder

Eligibility Criteria

Sex: All

Age: 7 - 17

Healthy Volunteers: Not accepted

Interventions

Traditional ultrasound biofeedback

Simplified ultrasound biofeedback

MPH HCl EREfficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years with ADHD

Recruiting

PHASE3

Sponsor:

Ironshore Pharmaceuticals and Development, Inc

Location:

Cincinnati OH, Saint Charles MO, Decatur GA, Memphis TNshow 9 more

Code:

NCT06431256

Conditions

Attention Deficit Hyperactivity Disorder

Eligibility Criteria

Sex: All

Age: 4 - 5

Healthy Volunteers: Not accepted

Interventions

HLD200 methylphenidate hydrochloride capsules

Placebo HLD200 capsules

NutritionStrength and Muscle Related Outcomes for Nutrition and Lung Function in CF

Recruiting

Sponsor:

Jaeb Center for Health Research

Location:

Cincinnati OH, Lexington KY, Cleveland OH, Chicago ILshow 18 more

Code:

NCT05639556

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BMI and lean mass index from DXA

Anthropometric Measurements

Hand-grip strength

Six-minute walk Test

Sit-to-Stand Test

BLU-263(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

Recruiting

PHASE2

PHASE3

Sponsor:

Blueprint Medicines Corporation

Location:

Cincinnati OH, Ann Arbor MI, Buffalo NY, Birmingham ALshow 6 more

Code:

NCT04910685

Conditions

Indolent Systemic Mastocytosis

Monoclonal Mast Cell Activation Syndrome

Smoldering Systemic Mastocytosis

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

Elenestinib

Placebo

Genetic RegistryParkinson's Foundation PD GENEration Genetic Registry

Recruiting

Sponsor:

Parkinson's Foundation

Location:

Cincinnati OH, Lexington KY, Indianapolis IN, Columbus OHshow 35 more

Code:

NCT04994015

Conditions

Parkinson's Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Lab Assay for seven genetic variants for Parkinson's Disease

IDE196 & CrizotinibIDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting

PHASE2

PHASE3

Sponsor:

IDEAYA Biosciences

Location:

Cincinnati OH, Cleveland OH, Nashville TN, Pittsburg PAshow 25 more

Code:

NCT05987332

Conditions

Metastatic Uveal Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IDE196

Crizotinib

Pembrolizumab

Ipilimumab

Nivolumab

ABBV-383A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma

Recruiting

PHASE1

Sponsor:

TeneoOne Inc.

Location:

Cincinnati OH, Fort Wayne IN, Nashville TN, Hinsdale ILshow 19 more

Code:

NCT05650632

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ABBV-383